Focus Partners Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.04M Buy
+900
New +$1.06M ﹤0.01% 1657
2025
Q3
– Sell
-300
Closed -$234K – 2266
2025
Q2
$234K Hold
300
– – ﹤0.01% 1791
2025
Q1
$248K Sell
300
-600
-67% -$499K ﹤0.01% 1664
2024
Q4
$695K Hold
900
– – ﹤0.01% 1187
2024
Q3
$797K Buy
+900
New +$809K ﹤0.01% 1008

Other funds holding LLY

Focus Partners Wealth's LLY Position: Q3 2026 in Review

Focus Partners Wealth increased its Eli Lilly (LLY) stake by 2.3% in Q3 2026, buying an estimated $6.92M and bringing the position to 265,911 shares worth $308M. The position accounts for 0.32% of the portfolio, ranked #64.

Focus Partners Wealth first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. The position peaked at $312M in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Focus Partners Wealth held 265,911 shares of Eli Lilly worth $308M as of Q3 2026.
  • Focus Partners Wealth bought 5,866 Eli Lilly shares in Q3 2026, an estimated $6.92M.
  • Eli Lilly made up 0.32% of Focus Partners Wealth's portfolio in Q3 2026, its #64 holding.
  • Focus Partners Wealth first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
  • Focus Partners Wealth's Eli Lilly position peaked at $312M in Q2 2026.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Focus Partners Wealth's 13F filing for Q3 2026, filed 12 Nov 2026.